½ÃÀ庸°í¼­
»óǰÄÚµå
1463136

¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Ä¡·áº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Lice Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 114 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ÀÌ Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 16¾ï 8,472¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ÀÌÁ¾ ±â»ýÃæ ¿À¿°ÀÇ À¯º´·üÀÇ ´ëÆøÀûÀÎ Áõ°¡, È¿´ÉÀÇ °³¼±, »ç¿ëÇϱ⠽¬¿î µµÆ÷ ¹æ¹ýÀÇ °³¹ß, »õ·Î¿î À¯È¿ ¼ººÐÀÇ ¹èÇÕ µî, Á¦Ç° ó¹æÀÇ ´ëÆøÀûÀÎ Áøº¸·Î À̾îÁö´Â ¿¬±¸ °³¹ß Ȱµ¿À̳ª ´ëó Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. °Ô´Ù°¡, ÀÌ °¨¿°°ú ÀÌ¿ë °¡´ÉÇÑ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇØ, ÀÇ·á Á¶Á÷À̳ª ´ç±¹¿¡ ÀÇÇÑ °è¹ß Ä·ÆäÀÎÀ̳ª ±³À° ÇÁ·Î±×·¥ÀÇ º¸±ÞÀÌ ÁøÇàµÇ°í ÀÖ´Â °Íµµ, ½ÃÀå ¼ºÀå¿¡ Ç÷¯½ºÀÇ ¿µÇâÀ» ¹ÌÄ¥ °Í °°½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 8¿ù, Mediker´Â "Mediker On Juey Gonel"À̶ó´Â À̸§ÀÇ »õ·Î¿î Ä·ÆäÀÎÀÇ ½ÃÀÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ä·ÆäÀÎÀ» ÅëÇØ ÀüÅëÀûÀÎ À̰¡ ¹ö¼¸¸¸À¸·Î´Â À̸¦ È¿°úÀûÀ¸·Î Á¦°ÅÇÒ ¼ö ¾øÀ¸¸ç Ãß°¡ Ä¡·á°¡ ÇÊ¿äÇÔÀ» ¼ÒºñÀÚ¿¡°Ô °è¸ùÇÕ´Ï´Ù.

°Ô´Ù°¡, ÀÌ È®»êÀº ÀÌ ±â»ýÁõÀ¸·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç ¼¼°è ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ È¿°úÀûÀ̰í Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ Ä¿Áö°í ½ÃÀå ¹ßÀü·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¸î ³â°£ ½ÃÀåÀº LED ¶óÀÌÆ®¿Í ¸¶ÀÌÅ©·ÎÇÁ·Î¼¼¼­¸¦ žÀçÇÑ Çõ½ÅÀûÀÎ ºøÇü ±â±¸ °³¹ß µî ±â¼úÀû Áøº¸ ¸é¿¡¼­ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

»ìÃæÁ¦ ³»¼ºÀ̳ª È­Çй°Áú¿¡ÀÇ ³ëÃâ¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö´Â °¡¿îµ¥, õ¿¬ ¼ººÐÀ̳ª ¹«ÇØÇÑ ¼ººÐÀ» ¿ä±¸ÇÏ´Â ¼ÒºñÀÚÀÇ ±âÈ£¸¦ ÃæÁ·½ÃŰ´Â ±â´ÉÀ» °®Ãá, º¸´Ù È¿°úÀûÀÎ ÀÌ ±¸Á¦¿ë ½ÅÁ¦Ç°À» °³¹ßÇÏ´Â Å« ±âȸ°¡ ±â¾÷ ¿¡ Á¸ÀçÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù, Torque Pharma´Â Torque Kvach ÆÛ½º³ÎÄÉ¾î ºê·£µåÀÇ ÀÏȯÀ¸·Î »õ·Î¿î ÀÌ Á¦°Å Å©¸² ¿ö½ÃÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ »õ·Î¿î Ãâ½Ã Á¦Ç°Àº õ¿¬ ¼ººÐÀÇ ÀÌÁ¡À» Ȱ¿ëÇÏ¿© ¸Ó¸®Ä«¶ôÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í È¿°úÀûÀ¸·Î À̸¦ Á¦°ÅÇÕ´Ï´Ù.

ÀÌ Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸Ó¸´´Ï ÁõÀº ¸Ó¸´´Ï ¹ßº´·ü Áõ°¡¿Í Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνĿ¡¼­ ¶Ñ·ÇÇÑ Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.

ÆíÀǼº ¹× ºñ¿ë È¿°ú¿Í °°Àº ÀÌÁ¡À¸·Î ÀÎÇØ OTC Á¦Ç° ºÎ¹®ÀÌ ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷Áö

º´¿ø¿¡¼­ Ä¡·á¹Þ´Â ȯÀÚ Áõ°¡¿Í 󹿾àÀÇ ÀÔ¼ö°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ º´¿ø ¾à±¹ ºÎ¹®ÀÌ °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹Ì´Â °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ Á¤ºñµÇ¾î ¼ÒºñÀÚÀÇ °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¼¼°è ½ÃÀåÀ» ¼®±Ç

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå ÀλçÀÌÆ®

  • ÀÌ Ä¡·á ½ÃÀå - À¯Åë ä³Î ½º³À¼¦
  • ÀÌ Ä¡·á ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ¶óÀÌÇÁ ½ºÅ¸Àϰú À§»ý ½À°üÀÇ º¯È­°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼Ó
      • ±ÔÁ¦ ´ç±¹¿¡ ÀÇÇÑ Á¦Ç° ½ÂÀÎ Áõ°¡
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • Ä¡·áºñÀÇ ³ôÀÌ¿Í ÀÎÁöµµÀÇ ³·À½
  • PESTEL ºÐ¼®
  • ÀÌ Ä¡·á ½ÃÀåÀÇ À¯Åë ä³ÎÀÇ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¸Ó¸®À̱â»ýÁõ
  • ¸öÀ̱â»ýÁõ
  • »ç¸é¹ßÀ̱â»ýÁõ

Á¦6Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • OTC Á¦Ç°
  • 󹿾à
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø ¹× Áø·á¼Ò
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ Ç÷§Æû
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀÌ Ä¡·á ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ÀÌ Ä¡·á ½ÃÀå Æò°¡, Áö¿ªº°(2019-2032³â)
  • ÀÌ Ä¡·á ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
    • ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
    • ºÏ¹Ì : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
    • ÀÌ Ä¡·á ½ÃÀå - ¹Ì±¹
    • ÀÌ Ä¡·á ½ÃÀå - ij³ª´Ù
  • ÀÌ Ä¡·á ½ÃÀå - À¯·´
    • À¯·´ : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
    • À¯·´ : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
    • À¯·´ : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
    • ÀÌ Ä¡·á ½ÃÀå - ¿µ±¹
    • ÀÌ Ä¡·á ½ÃÀå - ÇÁ¶û½º
    • ÀÌ Ä¡·á ½ÃÀå - µ¶ÀÏ
    • ÀÌ Ä¡·á ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ÀÌ Ä¡·á ½ÃÀå - ½ºÆäÀÎ
    • ÀÌ Ä¡·á ½ÃÀå - ³×´ú¶õµå
    • ÀÌ Ä¡·á ½ÃÀå - ·¯½Ã¾Æ
  • ÀÌ Ä¡·á ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
    • ÀÌ Ä¡·á ½ÃÀå - Áß±¹
    • ÀÌ Ä¡·á ½ÃÀå - Àεµ
    • ÀÌ Ä¡·á ½ÃÀå - ¸»·¹À̽þÆ
    • ÀÌ Ä¡·á ½ÃÀå - ÀϺ»
    • ÀÌ Ä¡·á ½ÃÀå - Àεµ³×½Ã¾Æ
    • ÀÌ Ä¡·á ½ÃÀå - Çѱ¹
  • ÀÌ Ä¡·á ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À̰¡½º Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
    • ÀÌ Ä¡·á ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ÀÌ Ä¡·á ½ÃÀå - UAE
    • ÀÌ Ä¡·á ½ÃÀå - À̽º¶ó¿¤
    • ÀÌ Ä¡·á ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ÀÌ Ä¡·á ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, À¯Çüº°(2019-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : À̰¡½º Ä¡·á ½ÃÀå, À¯Åë ä³Îº°(2019-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÌ Ä¡·á ½ÃÀå, Ä¡·áº°(2019-2032³â)
    • ÀÌ Ä¡·á ½ÃÀå - ¸ß½ÃÄÚ
    • ÀÌ Ä¡·á ½ÃÀå - ºê¶óÁú
    • ÀÌ Ä¡·á ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®´ë ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/°ø°³

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Arbor Pharmaceuticals LLC(US)
  • Bayer AG(Germany)
  • Insight Pharmaceuticals(US)
  • Omega Pharma NV(Belgium)
  • Parasol Laboratories(US)
  • Pfizer Inc.(US)
  • Prestige Brands Holding Inc.(US)
  • Sanofi SA(France)
  • Sumitomo Chemical Co. Ltd.(Japan)
  • TAA Industries(Australia)
  • TecLabs Inc.(US)
  • Tyratech Inc.(US)
JHS 24.05.14

The global lice treatment market size is expected to reach USD 1,684.72 million by 2032, according to a new study by Polaris Market Research. The report "Lice Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The substantial increase in the prevalence of lice parasites contamination worldwide and growing research & development activities or efforts leading to significant advancements in product formulations including improved efficacy, developing user-friendly application methods, and incorporating new active ingredients, are key factors driving the market growth. Additionally, rising proliferation for awareness campaigns and education programs by healthcare organizations and authorities to raise awareness about lice infestations and available treatment options, are further likely to have positive impact on market growth.

For instance, in August 2023, Mediker, announced the launch of its new campaign named "Mediker On Juey Gonel", that mainly aims at raising awareness about lice and its treatment options. Through this campaign, they will try to educate consumers that a conventional lice comb is not enough to effective remove lice and requires further treatments.

Furthermore, as lice infestations that is also knowns as pediculosis affect millions of people across the globe, thereby the growing need for effective and innovative treatments has led to evolution to the market. Over the last few years, the market has witnessed significant growth in terms of technological advancements such as development of innovative comb devices equipped with LED lights and microprocessors that are more effective in the detection and removing of lice from hair.

With the growing concerns about pesticide resistance and chemical exposure, there is significant opportunity for companies to develop new and more effective lice treatment products with capabilities to meet individual consumer preferences for natural and non-toxic ingredients. For instance, in November 2023, Torque Pharma, announced about the launch of its new Anti-Lice Cream Wash as a part of their Torque Kvach Personal Care Brand. The newly launched product has the benefits of natural ingredients to effective eliminate the lice without damaging or harming the hair because it contains blend of natural components like Reetha and Skikakai.

Lice Treatment Market Report Highlights

Pediculosis capitis segment accounted for notable share, on account of growing incidences of head lice and awareness about the importance of early detection

OTC products segment held the majority share, that is attributed to its benefits including convenience and cost-effectiveness

Hospital pharmacies segment will grow at fastest pace, due to rising number of patients undergoing treatments in hospitals and easy availability of prescription medications

North America dominated the global market, owing to region's well-established healthcare infrastructure and increased disposable income of consumers

The key market players include Insight Pharmaceuticals, Sumitomo Chemical, TecLabs, Omega Pharma, Bayer AG, and Arbor Pharmaceuticals

Polaris Market Research has segmented the lice treatment market report based on type, treatment, distribution channel, and region:

Lice Treatment, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Pediculosis Capitis
  • Pediculosis Corporis
  • Pediculosis Pubis

Lice Treatment, Treatment Outlook (Revenue - USD Million, 2023 - 2032)

  • OTC Products
  • Prescription Medications
  • Others

Lice Treatment, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Platform
  • Others

Lice Treatment, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lice Treatment Market Insights

  • 4.1. Lice Treatment Market - Distribution Channel Snapshot
  • 4.2. Lice Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Change in lifestyles and hygiene practices to drive market growth
      • 4.2.1.2. Increasing number of product approvals by regulatory bodies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of treatments and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lice Treatment Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lice Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lice Treatment Market, by Type, 2019-2032 (USD Million)
  • 5.3. Pediculosis Capitis
    • 5.3.1. Global Lice Treatment Market, by Pediculosis Capitis, by Region, 2019-2032 (USD Million)
  • 5.4. Pediculosis Corporis
    • 5.4.1. Global Lice Treatment Market, by Pediculosis Corporis, by Region, 2019-2032 (USD Million)
  • 5.5. Pediculosis Pubis
    • 5.5.1. Global Lice Treatment Market, by Pediculosis Pubis, by Region, 2019-2032 (USD Million)

6. Global Lice Treatment Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. OTC Products
    • 6.3.1. Global Lice Treatment Market, by OTC Products, by Region, 2019-2032 (USD Million)
  • 6.4. Prescription Medications
    • 6.4.1. Global Lice Treatment Market, by Prescription Medications, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Lice Treatment Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Lice Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals and Clinics
    • 7.3.1. Global Lice Treatment Market, by Hospitals and Clinics, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Lice Treatment Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Platform
    • 7.5.1. Global Lice Treatment Market, by Online Platform, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Lice Treatment Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Lice Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lice Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Lice Treatment Market - North America
    • 8.3.1. North America: Lice Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.4. Lice Treatment Market - U.S.
      • 8.3.4.1. U.S.: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.5. Lice Treatment Market - Canada
      • 8.3.5.1. Canada: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 8.4. Lice Treatment Market - Europe
    • 8.4.1. Europe: Lice Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.4. Lice Treatment Market - UK
      • 8.4.4.1. UK: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.5. Lice Treatment Market - France
      • 8.4.5.1. France: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.6. Lice Treatment Market - Germany
      • 8.4.6.1. Germany: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.7. Lice Treatment Market - Italy
      • 8.4.7.1. Italy: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.8. Lice Treatment Market - Spain
      • 8.4.8.1. Spain: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.9. Lice Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.10. Lice Treatment Market - Russia
      • 8.4.10.1. Russia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 8.5. Lice Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lice Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.4. Lice Treatment Market - China
      • 8.5.4.1. China: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.5. Lice Treatment Market - India
      • 8.5.5.1. India: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.6. Lice Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.7. Lice Treatment Market - Japan
      • 8.5.7.1. Japan: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.8. Lice Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.9. Lice Treatment Market - South Korea
      • 8.5.9.1. South Korea: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 8.6. Lice Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lice Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.4. Lice Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.5. Lice Treatment Market - UAE
      • 8.6.5.1. UAE: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.6. Lice Treatment Market - Israel
      • 8.6.6.1. Israel: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.7. Lice Treatment Market - South Africa
      • 8.6.7.1. South Africa: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 8.7. Lice Treatment Market - Latin America
    • 8.7.1. Latin America: Lice Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.4. Lice Treatment Market - Mexico
      • 8.7.4.1. Mexico: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.5. Lice Treatment Market - Brazil
      • 8.7.5.1. Brazil: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.6. Lice Treatment Market - Argentina
      • 8.7.6.1. Argentina: Lice Treatment Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Lice Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Lice Treatment Market, by Treatment, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arbor Pharmaceuticals LLC (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG (Germany)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Insight Pharmaceuticals (US)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Omega Pharma NV (Belgium)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Parasol Laboratories (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Pfizer Inc. (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Prestige Brands Holding Inc. (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sanofi SA (France)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sumitomo Chemical Co. Ltd. (Japan)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. TAA Industries (Australia)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. TecLabs Inc. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Tyratech Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦